Very much has happened in the research in gynaecological cancer since the founding of the MERMAID Project in 2000 and since the research in the first research project in ovarian cancer , MERMAID I, commenced, in 2003.

Learn more about MERMAIDs story by reading following timeline:

The fundraising and the research are completed


The fundraising and the research for MERMAID III continue


The fundraising and the research for MERMAID III continue


The fundraising and the research for MERMAID III continue


The fundraising for  MERMAID III continues
The research in MERMAID III commences


The research in MERMAID II is expected to be concluded in the end of the year

Fundraising MERMAID III
The research in MERMAID II was concluded.


Fundraising MERMAID III


MERMIADs scientific committee recommends that the research in the new project MERMAID III shall concentrate on ovarian cancer as inMERMAID I. The researchers will focus on finding methods to detect the disease at an early stage. The fundraising will begin in the end of the year.


Grace to generous donators MERMAID II reaches full funding in respect of the project which has a budget on 26.3. million Danish kroner.

Again the MERMAID II project obtain a good and positive evaluation from the independent group of experts , the Monitoring Group, which among other things describe the research as relevant, important and competent. MERMAIDs Scientific Committee works on a definition of a new project MERMAID III.


In October the first results of the research of MERMAID II is published in the scientific journal, The Journal of The National Cancer Institute. The results are a breakthrough and of significant international importance.

The research in MERMAID I is finalized in December 2010. The independent audit committee (”IAC”) writes in its final evauation:

“The IAC can conclude, without hesitation, that this has been one of the most important and productive scientific initiatives within the field of gynecological cancer research. The Mermaid I has not only produced new knowledge for the benefit of women baring the risk of or with ovarian cancer, but also sets the scene for the future scientific activity within this area.”

In the first evaluation of the research of MERMAID II the professors in IAC conclude:

…”The progress during the last two years is very impressive and the handling of the technologies used by the investigators is very competent…………..
The project has resulted in important new knowledge in relation to the natural history of HPV infection and cervical neoplasia”…

Several and substantial donations are received during the year. The fundraising continues!


MERMAIDs “Præsidium” changes its name to Advisory Committee (See “Who are we”).


Members of the Steering Committee, Suzanne B D L Kürstein and Christen W. Obel are replaced by KristianEngsig and Stephan N. Treschow who becomes a chairman of the Steering Committee and the Advisory Committee (See “Who are we”).


Focus on raising funds for Mermaid II. The Danish Singer Lis Sørensen accepts to be a Goodwill Amabassador for MERMAID. Other Goodwill Amabassdors in MERMAID are Bente and Peter Schmeichel.


Fund raising for MERMAID II – Cervical Cancer – research in biological and genetic markers is initiated.


An independent scientific monitoring group is set up with the aim of auditing the annual scientific report on MERMAID’s projects.

The group is composed of:

  • Professor Bent Ottesen, Centre
    Director of the Juliane Marie
    Centre, Copenhagen University
  • Professor Per Oluf Janson,
    Shalgrenska University Hospital,
    Gothenburg, Sweden
  • Professor Henrik Hertz,
    Copenhagen University Hospital,
    Chairman of the Danish Children’s
    Cancer Foundation
  • Professor Ian Jacobs, Institute of
    Women’s Health, University
    College London, England.

The MERMAID steering committee is very pleased to have received full funding for MERMAID I, and a new project is chosen in co-operation with the scientific monitoring group.


2004. HH Princess Alexandra joins the steering committee.

Raising funds for MERMAID I is intensified, and an administrative co-ordinator is employed with primary focus on fundraising.


2003. A steering group is formed, to have prime responsibility forMERMAID’s funds, administration, fundraising and choice of which gynaecological cancer projects to support. The steering committee:

  • Peter Vagn-Jensen, Director
  • Professor Susanne Krüger Kjær, M.D., DMSc.
  • Jan Blaakær, M.D., DMSc.
  • Claus Høgdall, M.D., DMsc.
  • Suzanne B.D.L. Kürstein, Director
  • Christen W. Obel, Consultant
  • Henrik Schrøder, Company Director

2002. The scientifically responsible research group of MERMAID I is formed and composed of:

  • Professor Susanne Krüger Kjær, M.D.,
    DMSc. of the Danish Cancer Society
    /Copenhagen University Hospital
  • Jan Blaakær, M.D., DMSc., Skejby
  • Claus Høgdall, M.D., DMSc.,
    Copenhagen University Hospital
  • Professor Ian Jacobs, University
    College London

Proper applications are forwarded to privat foundations, and the first commitments to finance the project are received.

MERMAID is established as a legal entity, the first researchers are employed, and the real research is started.

2003 - 2002

2001. When the projects have been defined in the research group, the first potential sources of finance are contacted.

2000. The idea of MERMAID I is created in a co-operation between:

  • Peter Vagn-Jensen, Director
  • Professor Susanne Krüger Kjær, M.D., DMSc. of the Danish Cancer Society/Copenhagen University Hospital
  • Professor Ian Jacobs, University College London
2001 - 2000